Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting

Authors

Howard M. Lando, George Washington UniversityFollow
May Alattar, Medical Specialists of Northern Virginia, Alexandria, VA
Anuradha P. Dua, Medical Specialists of Northern Virginia, Alexandria, VA

Document Type

Journal Article

Publication Date

7-1-2012

Journal

Endocrine Practice

Volume

Volume 18, Issue 4

Inclusive Pages

472-477

Keywords

Diabetes Mellitus; Type 2--drug therapy; Dipeptidyl-Peptidase IV Inhibitors--adverse effects; Glucagon-Like Peptide 1--agonists; Hypoglycemic Agents--adverse effects; Pancreas--drug effects; Pancreatitis--chemically induced; Receptors; Glucagon--agonists

APA Citation

Lando, H., Alattar, M., & Dua, A. (2012). Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting. Endocrine Practice, 18(4), 472-477.

Peer Reviewed

1